|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Legal settlement | |||||
| Restructuring related charges | |||||
| Restructuring related charges, net | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest income | |||||
| Interest expense | |||||
| Interest income and other, net | |||||
| Interest and other income (loss), net | |||||
| Income (loss) before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net income (loss) | |||||
| Comprehensive loss, net of tax | |||||
| Net income (loss) per share — basic (in dollars per share) | |||||
| Net income (loss) per share — diluted (in dollars per share) | |||||
| Weighted-average shares: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
